Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Leiomyoma 6Menorrhagia 5Pregnancy Complications 1Observational Study 1Lymphoma 1Endometriosis 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

relugolix 4Sutures 2vilaprisan 1tibolone 1cetrorelix 1Uterine Myomectomy 1Triptorelin Pamoate 1Transcranial Direct Current Stimulation 1Tablets 1Surgical Procedures, Operative 1Surgical Instruments 1Rocuronium 1Robotic Surgical Procedures 1Radiotherapy 1Radiation 1Norethindrone Acetate 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Indocyanine Green 1Incidence 1Immunonutrition Diet 1Hysteroscopy 1Hysterectomy 1Gonadotropins 1Gonadotropin-Releasing Hormone 1Fluconazole 1Estradiol 1Endoscopes 1Electrocoagulation 1Danazol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometriosis × Norethindrone Acetate × Clear all
NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting
530 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡